Insights

Innovative Diagnostic Technology Genalyte specializes in delivering accurate, real-time blood diagnostics at the point of care, making it a prime candidate for sales opportunities involving healthcare providers seeking rapid, reliable testing solutions.

Strong Growth Funding With an oversubscribed funding round of $50 million and recent strategic partnerships, Genalyte is actively expanding its product offerings and market reach, indicating openness to new technology integrations and solutions.

Leadership and Strategic Partnerships The appointment of a new CEO and participation in high-profile health events like Abu Dhabi Global Health Week suggest the company is positioning itself for international growth and increased market presence.

Regulatory Approvals Receiving Emergency Use Authorization for COVID-19 antibody testing demonstrates Genalyte's capability to meet regulatory standards, opening avenues for sales in government, hospital, and private lab segments.

Tech Stack & Compliance Utilizing industry-standard frameworks like ISO 13485 and various tech tools enables compliance and seamless integration, presenting opportunities for suppliers and partners with compatible healthcare IT solutions.

Genalyte, Inc. Tech Stack

Genalyte, Inc. uses 8 technology products and services including ISO 13485, Microsoft Access, Amazon Simple Email Service, and more. Explore Genalyte, Inc.'s tech stack below.

  • ISO 13485
    Certificates
  • Microsoft Access
    Database Management Software
  • Amazon Simple Email Service
    Email
  • Twemoji
    Font Scripts
  • Playwright
    Frameworks And Libraries
  • UNIX
    Operating Systems
  • Android
    Programming Languages
  • Max Mega Menu
    Widgets

Media & News

Genalyte, Inc.'s Email Address Formats

Genalyte, Inc. uses at least 2 format(s):
Genalyte, Inc. Email FormatsExamplePercentage
First.Last@genalyte.comJohn.Doe@genalyte.com
41%
First@genalyte.comJohn@genalyte.com
30%
Last@genalyte.comDoe@genalyte.com
27%
FirstLast@genalyte.comJohnDoe@genalyte.com
2%
First.Last@tel.comJohn.Doe@tel.com
96%
FLast@tel.comJDoe@tel.com
3%
Last.First@tel.comDoe.John@tel.com
1%

Frequently Asked Questions

What is Genalyte, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Genalyte, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genalyte, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Genalyte, Inc.'s official website is genalyte.com and has social profiles on LinkedInCrunchbase.

What is Genalyte, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Genalyte, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genalyte, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Genalyte, Inc. has approximately 94 employees across 2 continents, including North AmericaEurope. Key team members include Vice President And General Manager - Sales: L. D.Fellow Tel-Us And Vice President Technology Development: G. L.Vice-President: M. X.. Explore Genalyte, Inc.'s employee directory with LeadIQ.

What industry does Genalyte, Inc. belong to?

Minus sign iconPlus sign icon
Genalyte, Inc. operates in the Biotechnology Research industry.

What technology does Genalyte, Inc. use?

Minus sign iconPlus sign icon
Genalyte, Inc.'s tech stack includes ISO 13485Microsoft AccessAmazon Simple Email ServiceTwemojiPlaywrightUNIXAndroidMax Mega Menu.

What is Genalyte, Inc.'s email format?

Minus sign iconPlus sign icon
Genalyte, Inc.'s email format typically follows the pattern of First.Last@genalyte.com. Find more Genalyte, Inc. email formats with LeadIQ.

How much funding has Genalyte, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Genalyte, Inc. has raised $155M in funding. The last funding round occurred on Mar 07, 2023 for $13M.
Genalyte, Inc. logo

Genalyte, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

Genalyte, Inc. is a biotechnology research company located in San Diego, California, at 6620 Mesa Ridge Road, 92121. The company employs between 51 and 200 people. Genalyte delivers real-time, point-of-care blood diagnostics and analytics, with a website at genalyte.com. It has developed SARS-CoV-2 diagnostics, including a SARS-CoV-2 Multi-Antigen Serology Panel, and received FDA Emergency Use Authorization for a rapid COVID-19 antibody test in 2020. The company has engaged in financing rounds and partnerships, including Verily as lead investor in a 2021 round and a strategic partnership with Burjeel Holdings announced in 2025 at Abu Dhabi Global Health Week. Revenue is reported in the range of $25 million to $50 million, and the company has raised funding.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $155M

    Genalyte, Inc. has raised a total of $155M of funding over 5 rounds. Their latest funding round was raised on Mar 07, 2023 in the amount of $13Mas a series_c.

  • $25M$50M

    Genalyte, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $155M

    Genalyte, Inc. has raised a total of $155M of funding over 5 rounds. Their latest funding round was raised on Mar 07, 2023 in the amount of $13Mas a series_c.

  • $25M$50M

    Genalyte, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.